Velcade (Bortezomib) News and Research

RSS
Velcade is a drug used to treat multiple myeloma that has gotten worse during treatment with other anticancer drugs. It is also used to treat mantle cell lymphoma in patients who have already received at least one other type of treatment. Velcade is also being studied in the treatment of other types of cancer. It is a type of proteasome inhibitor and a type of dipeptidyl boronic acid. Also called bortezomib and PS-341.
Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits